|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2006. CA Cancer J Clin. 56:106–130. 2006. View Article : Google Scholar
|
|
2
|
Khuri FR, Lee JJ, Lippman SM, et al:
Randomized phase III trial of low-dose isotretinoin for prevention
of second primary tumors in stage I and II head and neck cancer
patients. J Natl Cancer Inst. 98:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gasparotto D and Maestro R: Molecular
approaches to the staging of head and neck carcinomas (review). Int
J Oncol. 31:175–180. 2007.PubMed/NCBI
|
|
4
|
Shibata M, Kodani I, Osaki M, et al:
Cyclo-oxygenase-1 and -2 expression in human oral mucosa,
dysplasias and squamous cell carcinomas and their pathological
significance. Oral Oncol. 41:304–312. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kodani I, Shomori K, Osaki M, Kuratate I,
Ryoke K and Ito H: Expression of minichromosome maintenance 2
(MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in
the normal-dysplasia-carcinoma sequence of the oral mucosa.
Pathobiology. 69:150–158. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lumerman H, Freedman P and Kerpel S: Oral
epithelial dysplasia and the development of invasive squamous cell
carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
79:321–329. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silverman S Jr, Gorsky M and Lozada F:
Oral leukoplakia and malignant transformation. A follow-up study of
257 patients. Cancer. 53:563–568. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Banoczy J and Csiba A: Occurrence of
epithelial dysplasia in oral leukoplakia. Analysis and follow-up
study of 12 cases. Oral Surg Oral Med Oral Pathol. 42:766–774.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kalavrezos N and Bhandari R: Current
trends and future perspectives in the surgical management of oral
cancer. Oral Oncol. 46:429–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guimaraes DP and Hainaut P: TP53: a key
gene in human cancer. Biochimie. 84:83–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oren M: Decision making by p53: life,
death and cancer. Cell Death Differ. 10:431–442. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gasco M and Crook T: The p53 network in
head and neck cancer. Oral Oncol. 39:222–231. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brosh R and Rotter V: When mutants gain
new powers: news from the mutant p53 field. Nat Rev Cancer.
9:701–713. 2009.PubMed/NCBI
|
|
14
|
Soussi T and Béroud C: Assessing TP53
status in human tumours to evaluate clinical outcome. Nat Rev
Cancer. 1:233–240. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Perisanidis C, Perisanidis B, Wrba F, et
al: Evaluation of immunohistochemical expression of p53, p21, p27,
cyclin D1, and Ki67 in oral and oropharyngeal squamous cell
carcinoma. J Oral Pathol Med. 41:40–46. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Coutinho-Camillo CM, Lourenco SV,
Nishimoto IN, Kowalski LP and Soares FA: Nucleophosmin, p53, and
Ki-67 expression patterns on an oral squamous cell carcinoma tissue
microarray. Hum Pathol. 41:1079–1086. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kato K, Kawashiri S, Tanaka A, et al:
Predictive value of measuring p53 labeling index at the invasive
front of oral squamous cell carcinomas. Pathol Oncol Res. 14:57–61.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oliveira LR, Ribeiro-Silva A, Costa JP,
Simões AL, Matteo MA and Zucoloto S: Prognostic factors and
survival analysis in a sample of oral squamous cell carcinoma
patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
106:685–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
International Union Against Cancer. TNM
Classification of Malignant Tumours. Wiley-Liss; New York, NY:
2000
|
|
20
|
Howaldt HP, Kainz M, Euler B and Vorast H:
Proposal for modification of the TNM staging classification for
cancer of the oral cavity. DOSAK J Craniomaxillofac Surg.
27:275–288. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kreppel M, Drebber U, Eich HT, et al:
Combined-modality treatment in advanced oral squamous cell
carcinoma: Primary surgery followed by adjuvant concomitant
radiochemotherapy. Strahlenther Onkol. 187:555–560. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SY, Nam SY, Choi SH, Cho KJ and Roh
JL: Prognostic value of lymph node density in node-positive
patients with oral squamous cell carcinoma. Ann Surg Oncol.
18:2310–2317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pillai KR, Sujathan K, Madhavan J and
Abraham EK: Significance of silver-stained nucleolar organizer
regions in early diagnosis and prognosis of oral squamous cell
carcinoma: a multivariate analysis. In Vivo. 19:807–812.
2005.PubMed/NCBI
|
|
24
|
Iype EM, Pandey M, Mathew A, Thomas G and
Nair MK: Squamous cell cancer of the buccal mucosa in young adults.
Br J Oral Maxillofac Surg. 42:185–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Girod SC, Krueger G and Pape HD: p53 and
Ki 67 expression in preneoplastic and neoplastic lesions of the
oral mucosa. Int J Oral Maxillofac Surg. 22:285–288. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Olivier M, Hainaut P and Borresen-Dale A:
Prognostic and predictive value of TP53 mutations in human cancer.
25 Years of p53 Research. Hainaut P and Wiman K: Springer;
Dordrecht, the Netherlands: pp. 321–338. 2005, View Article : Google Scholar
|
|
27
|
Jäättelä M: Multiple cell death pathways
as regulators of tumour initiation and progression. Oncogene.
23:2746–2756. 2004.PubMed/NCBI
|
|
28
|
Igney FH and Krammer PH: Death and
anti-death: tumour resistance to apoptosis. Nat Rev Cancer.
2:277–288. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng H, Takahashi H, Murai Y, et al:
Pathobiological characteristics of intestinal and diffuse-type
gastric carcinoma in Japan: an immunostaining study on the tissue
microarray. J Clin Pathol. 60:273–277. 2007. View Article : Google Scholar
|
|
30
|
Jackson JG, Pant V, Li Q, et al:
p53-mediated senescence impairs the apoptotic response to
chemotherapy and clinical outcome in breast cancer. Cancer Cell.
21:793–806. 2012. View Article : Google Scholar : PubMed/NCBI
|
